Telephone-Based Counseling for Depression in Parkinson's Disease
TH-CBT
Improving Access to Depression Care in Parkinson's Disease: A Telehealth Approach
1 other identifier
interventional
72
1 country
1
Brief Summary
There is a critical need for treatments that address depression and barriers to mental health care in Parkinson's disease (PD). This randomized-controlled trial will evaluate a 10-session telephone-guided cognitive behavioral self-help program (TH-CBT) for depression in PD (dPD). 72 people with dPD (and their caregivers) will receive either TH-CBT plus enhanced usual care (INTERVENTION GROUP) or enhanced usual care only (CONTROL GROUP). Groups will be compared at baseline, midpoint, endpoint, and 1 and 6 months post-treatment. Participants assigned to the control group with have the opportunity to receive the experimental intervention (TH-CBT) after the data collection period (e.g., after the 6-month follow-up evaluation). Given the public health impact of improved depression treatment in PD, the knowledge to be gained may be significant and the project could directly impact clinical practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable depression
Started Jul 2015
Typical duration for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2015
CompletedFirst Submitted
Initial submission to the registry
July 21, 2015
CompletedFirst Posted
Study publicly available on registry
July 22, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2018
CompletedFebruary 19, 2019
February 1, 2019
3 years
July 21, 2015
February 15, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Depression on the Hamilton Depression Rating Scale
clinician-administered scale- depression
9 months
Secondary Outcomes (3)
Treatment Response on the Clinical Global Impression- Improvement Scale
9- months
Anxiety on the Hamilton Anxiety Rating Scale
9-months
Quality of life on the SF-36
9-months
Study Arms (2)
TH-CBT
EXPERIMENTALThe treatment works by teaching people with PD (PWP) the coping skills needed to manage their emotional reactions to the numerous challenges posed by the disease. Specifically, the treatment targets maladaptive thought patterns (e.g., I have no control; I am helpless) and behaviors (e.g., social isolation, lack of exercise, poor sleep habits, excessive worry), and critically, provides caregivers with the tools needed to encourage the PWPs' practice of their newly acquired coping skills. Treatment is administered over the phone and no travel is required.
Enhanced Usual Care
OTHERAll participants will continue to receive their routine medical treatment under the supervision of their personal doctors (e.g., neurologists, psychiatrists, primary care physicians, therapists) while participating in the study. This routine treatment (e.g., usual care) will be further enhanced with the provision of written educational materials for effective coping with PD, the close clinical monitoring of depressive symptoms by study staff, and the provision of counseling resources in the local community.
Interventions
Telephone-Based Cognitive Behavioral Therapy (TH-CBT). A 10-session treatment protocol that incorporates behavioral activation, thought monitoring and restructuring, relaxation training, worry control, sleep hygiene, and caregiver psychoeducation and support
Community-based treatment as usual and supplemental reading material
Eligibility Criteria
You may qualify if:
- Confirmed diagnosis of Parkinson's disease.
- Clinically significant depressive symptoms (e.g., symptoms are pervasive, distressing, and make life harder). The presence of a formal depressive disorder will be determined by study staff based on standardized criteria (e.g., SCID).
- years old
- Stable medication regimen ≥ 6 weeks
- No change in mental health treatment in the past 2 months
- Family member or friend willing to participate
- Access to a telephone
- Live in the United States of America (USA)
You may not qualify if:
- Suicidal plans or intent
- Probable Dementia or Significant Cognitive Impairment
- Significant motor fluctuations (i.e., ≥ 50% of the day)
- Unstable medical conditions
- Bipolar, Psychotic Spectrum, or Substance Abuse Disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rutgers University-Robert Wood Johnson Medical School
Piscataway, New Jersey, 08854, United States
Related Publications (1)
Dobkin RD, Mann SL, Gara MA, Interian A, Rodriguez KM, Menza M. Telephone-based cognitive behavioral therapy for depression in Parkinson disease: A randomized controlled trial. Neurology. 2020 Apr 21;94(16):e1764-e1773. doi: 10.1212/WNL.0000000000009292. Epub 2020 Apr 1.
PMID: 32238507DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Roseanne D Dobkin, PhD
Rutgers Robert Wood Johnson Medical School
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Psychiatry
Study Record Dates
First Submitted
July 21, 2015
First Posted
July 22, 2015
Study Start
July 1, 2015
Primary Completion
June 30, 2018
Study Completion
June 30, 2018
Last Updated
February 19, 2019
Record last verified: 2019-02